3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
2
Completed
2
Recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Conization
3
Papillomavirus Vaccines
2
Human Papillomavirus DNA Tests
2
Colposcopy
2
pembrolizumab
1
epigallocatechin gallate
1
artesunic acid
1
artemisinin
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Restraint, Physical
1
Pregnancy Tests
1
Liquid Biopsy
1
Imiquimod
1
Hysterectomy
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Fenofibrate
1
Chemoradiotherapy
1
Blood Specimen Collection
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Uterine Cervical Dysplasia
×
Acetic Acid
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled